165 related articles for article (PubMed ID: 2883647)
1. Watery diarrhea syndrome caused by multihormonal malignant pancreatic islet cell tumor secreting somatostatin, vasoactive intestinal peptide, serotonin, and prostaglandin E--a clinicopathological, biochemical, immunohistochemical, and ultrastructural study.
Chen YF; Liu TH; Chen SP; Pan GZ; Lu XH; Lu GJ; Zhong SX; Cai LX; Cui QC; Ran QY
Pancreas; 1986; 1(1):80-9. PubMed ID: 2883647
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal polypeptide-, somatostatin-, and calcitonin-producing adrenal pheochromocytoma associated with the watery diarrhea (WDHH) syndrome. First case report with immunohistochemical findings.
Viale G; Dell'Orto P; Moro E; Cozzaglio L; Coggi G
Cancer; 1985 Mar; 55(5):1099-106. PubMed ID: 2857107
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
[TBL] [Abstract][Full Text] [Related]
4. VIPoma syndrome.
Krejs GJ
Am J Med; 1987 May; 82(5B):37-48. PubMed ID: 3035922
[TBL] [Abstract][Full Text] [Related]
5. Secretory diarrhea with islet cell hyperplasia and increased immunohistochemical reactivity to serotonin.
Nishiyama RH; Thompson NW; Lloyd R; Augur NA
Surgery; 1984 Dec; 96(6):1038-44. PubMed ID: 6095478
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors.
Reubi JC; Heitz PU; Gyr K
Lancet; 1987 Mar; 1(8535):741-2. PubMed ID: 2882148
[No Abstract] [Full Text] [Related]
7. A combined glucagonoma and VIPoma syndrome. First pathologic and clinical report.
Cavallo-Perin P; De Paoli M; Guiso G; Sapino A; Papotti M; Coda R; Pagano G
Cancer; 1988 Dec; 62(12):2576-9. PubMed ID: 2847862
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide producing neuroblastoma.
Cooney DR; Voorhess ML; Fisher JE; Brecher M; Karp MP; Jewett TC
J Pediatr Surg; 1982 Dec; 17(6):821-25. PubMed ID: 6298396
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical and ultrastructural abnormalities of islet tissue in patients with VIP-producing tumors of the pancreas.
Bani Sacchi T; Bani D; Biliotti G
Pancreas; 1992; 7(5):601-10. PubMed ID: 1355293
[TBL] [Abstract][Full Text] [Related]
10. A patient with Verner-Morrison's syndrome--a vasoactive intestinal peptide (VIP)-mediated watery diarrhoea syndrome?
Meuwese-Arends MT; Yap SH; Van Tongeren JH
Neth J Med; 1980; 23(2):107-10. PubMed ID: 6246463
[No Abstract] [Full Text] [Related]
11. Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet cell apudoma.
Devine BL; Carmichael HA; Russell RI; Joffe SN
Postgrad Med J; 1978 Aug; 54(634):566-70. PubMed ID: 215990
[TBL] [Abstract][Full Text] [Related]
12. Primary endocrine-secreting pancreatic tumors.
Macaron C
Am Fam Physician; 1980 Apr; 21(4):94-8. PubMed ID: 6103668
[TBL] [Abstract][Full Text] [Related]
13. Secretin, cholecystokinin, and vasoactive intestinal polypeptide in pancreatic cholera.
Achord JL
Ann Intern Med; 1986 Oct; 105(4):632. PubMed ID: 3019205
[No Abstract] [Full Text] [Related]
14. Watery diarrhoea and a vasoactive intestinal peptide secreting ganglioneuroma.
Dorney SF; Kamath KR; Shulkes AA; Middleton AW
Med J Aust; 1984 Jan; 140(2):97-9. PubMed ID: 6319979
[TBL] [Abstract][Full Text] [Related]
15. Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy.
Virgolini I; Kurtaran A; Leimer M; Kaserer K; Peck-Radosavljevic M; Angelberger P; Hübsch P; Dvorak M; Valent P; Niederle B
J Nucl Med; 1998 Sep; 39(9):1575-9. PubMed ID: 9744346
[TBL] [Abstract][Full Text] [Related]
16. Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome.
Yiangou Y; Williams SJ; Bishop AE; Polak JM; Bloom SR
J Clin Endocrinol Metab; 1987 Jan; 64(1):131-9. PubMed ID: 3023426
[TBL] [Abstract][Full Text] [Related]
17. [Vasoactive intestinal peptide (VIP) in the Verner-Morrison syndrome (author's transl)].
Grenier JF; Marescaux J; Michel F; Sava G; Kachelhoffer J
Nouv Presse Med; 1979 Apr; 8(18):1505-8. PubMed ID: 224378
[TBL] [Abstract][Full Text] [Related]
18. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.
Ruskoné A; René E; Chayvialle JA; Bonin N; Pignal F; Kremer M; Bonfils S; Rambaud JC
Dig Dis Sci; 1982 May; 27(5):459-66. PubMed ID: 6122550
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide secreting tumours in children: a case report with literature review.
Quak SH; Prabhakaran K; Kwok R; O'Reilly AP
Aust Paediatr J; 1988 Feb; 24(1):55-8. PubMed ID: 2833214
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic endocrine tumours associated with WDHA syndrome. An immunohistochemical and electron microscopic study.
Ooi A; Kameya T; Tsumuraya M; Yamaguchi K; Abe K; Shimosato Y; Yanaihara N
Virchows Arch A Pathol Anat Histopathol; 1985; 405(3):311-23. PubMed ID: 2579503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
